TWA
RANI icon

TPB Wealth Advisors’s Rani Therapeutics RANI Stock Holding History

TPB Wealth Advisors’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$248K Hold
48,129
– – 0.14% 35
2022
Q4 		$284K Hold
48,129
– – 0.15% 41
2022
Q3 		$461K Sell
48,129
-23,682
-33% -$251K 0.22% 34
2022
Q2 		$742K Buy
+71,811
New +$824K 0.33% 37

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ASGS
Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return

TPB Wealth Advisors's RANI Position: Q1 2023 in Review

TPB Wealth Advisors held its Rani Therapeutics (RANI) position steady in Q1 2023 at 48,129 shares worth $248K. The position accounts for 0.14% of the portfolio, ranked #35.

TPB Wealth Advisors first reported a position in RANI in Q2 2022 and has held it in 4 quarters since. The position peaked at $742K in Q2 2022. 36 funds tracked by Wall St. Rank hold RANI as of Q1 2023.

  • TPB Wealth Advisors held 48,129 shares of Rani Therapeutics worth $248K as of Q1 2023.
  • TPB Wealth Advisors left its Rani Therapeutics share count unchanged in Q1 2023.
  • Rani Therapeutics made up 0.14% of TPB Wealth Advisors's portfolio in Q1 2023, its #35 holding.
  • TPB Wealth Advisors first reported a position in Rani Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • TPB Wealth Advisors's Rani Therapeutics position peaked at $742K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2023.

Based on TPB Wealth Advisors's 13F filing for Q1 2023, filed 23 May 2023.